A. The effect of trastuzumab on the viability of the BT-474 (parental,... | Download Scientific Diagram
Tumorsphere Culture of Human Breast Cancer Cell Lines
Biomedicines | Free Full-Text | Human Blood Serum Inhibits Ductal Carcinoma Cells BT474 Growth and Modulates Effect of HER2 Inhibition
Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation | Nature Communications
.jpg "Buy BT-474 | Cell Lines | CLS.shop")
Buy BT-474 | Cell Lines | CLS.shop
BT474 cells | PLOS ONE
Cancers | Free Full-Text | MCF-7 Drug Resistant Cell Lines Switch Their Lipid Metabolism to Triple Negative Breast Cancer Signature
.jpg "Buy BT-474 | Cell Lines | CLS.shop")
Buy BT-474 | Cell Lines | CLS.shop
CIMB | Free Full-Text | In Vitro Evidence of Differential Immunoregulatory Response between MDA-MB-231 and BT-474 Breast Cancer Cells Induced by Bone Marrow-Derived Mesenchymal Stromal Cells Conditioned Medium
Human Breast Carcinoma, ductal cell line BT-474-BHC11100222
.jpg "Buy BT-474 | Cell Lines | CLS.shop")
Buy BT-474 | Cell Lines | CLS.shop
Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines
Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines | Scientific Reports
Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation | Breast Cancer Research | Full Text
BT-474 Clone 5 - CRL-3247 | ATCC
Conditioned media from MCF7 and BT474 breast cancer cells induce insulin resistance in skeletal muscle myotubes. Mona S. Alia, X
Does the morphology of BT474 cells change in an older passage (p16)? | ResearchGate
Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients | PNAS
Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines
Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment | PLOS ONE
BT-474 - HTB-20 | ATCC
Growth of BT-474 cells incubated with the conditioned media of MCF-10A... | Download Scientific Diagram
Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer | Breast Cancer Research | Full Text
